• Twitter
  • Linkedin
  • Careers
  • News
  • Contact
Amplyx
  • Who We Are
  • Our Focus
  • Our Pipeline
  • Patient Community
  • Investors
  • Menu
2019, Press Release

Amplyx Announces Presentations on Fosmanogepix (APX001) at IDWeek 2019 and the 9th Congress on Trends in Medical Mycology (TIMM-9)

Read more
September 24, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-24 05:00:442020-08-18 13:49:45Amplyx Announces Presentations on Fosmanogepix (APX001) at IDWeek 2019 and the 9th Congress on Trends in Medical Mycology (TIMM-9)
2019, Press Release

Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients

Read more
September 16, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-16 11:08:172020-08-18 13:49:53Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients
2019, Press Release

Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia

Read more
September 16, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-16 11:06:362020-06-08 10:49:55Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
2019, Press Release

FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications

Read more
September 9, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-09-09 05:00:122020-05-19 10:37:20FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications
2019, Press Release

Amplyx Pharmaceuticals Announces Presentations at the 29th ECCMID in Amsterdam

Read more
April 12, 2019/by Lauren Fish
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 Lauren Fish https://amplyx.com/wp-content/uploads/2019/11/logo.svg Lauren Fish2019-04-12 05:48:132020-05-19 10:37:04Amplyx Pharmaceuticals Announces Presentations at the 29th ECCMID in Amsterdam
2019, Press Release

FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis

Read more
February 11, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-02-11 06:12:262020-05-19 10:36:43FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
2019, Press Release

Antimicrobials Working Group Announces Updates to Leadership Team

Read more
January 31, 2019/by eallison
https://amplyx.com/wp-content/uploads/2019/11/logo.svg 0 0 eallison https://amplyx.com/wp-content/uploads/2019/11/logo.svg eallison2019-01-31 15:12:552020-02-26 10:50:19Antimicrobials Working Group Announces Updates to Leadership Team
Amplyx © Copyright 2021 Privacy Policy EU Privacy Policy
Scroll to top